Literature DB >> 11704822

RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho.

M V Barone1, L Sepe, R M Melillo, A Mineo, G Santelli, C Monaco, M D Castellone, D Tramontano, A Fusco, M Santoro.   

Abstract

Thyroid papillary carcinomas are characterized by RET/PTC rearrangements that cause the tyrosine kinase domain of the RET receptor to fuse with N-terminal sequences encoded by heterologous genes. This results in the aberrant expression of a ligand-independent and constitutively active RET kinase. We analysed actin reorganization induced by the RET/PTC1 oncogene in PC Cl 3 rat thyroid epithelial cells. Differently from oncogenes Src, Ras and Raf, RET/PTC1 caused actin filaments to form prominent stress fibers. Moreover, stress fibers were identified in human thyroid papillary carcinoma cell lines harboring RET/PTC1 rearrangements but not in thyroid carcinoma cells negative for RET/PTC rearrangements. RET/MEN 2A, a constitutively active but unrearranged membrane-bound RET oncoprotein, did not induce stress fibers in PC Cl 3 cells. Induction of stress fibers by RET/PTC1 was restricted to thyroid cells; it did not occur in NIH3T3 fibroblasts or MCF7 mammary cells. RET/PTC1-mediated stress fiber formation depended on Rho but not Rac small GTPase activity. In addition, inhibition of Rho, but not of Rac, caused apoptosis of RET/PTC1-expressing thyroid cells. We conclude that Rho is implicated in the actin reorganization and cell survival mediated by the chimeric RET/PTC1 oncogene in thyroid epithelial cells, both phenotypes being cell type- and oncogene type-specific.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704822     DOI: 10.1038/sj.onc.1204886

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease.

Authors:  Maria Vittoria Barone; Anna Gimigliano; Gabriella Castoria; Giovanni Paolella; Francesco Maurano; Franco Paparo; Maria Maglio; Alba Mineo; Erasmo Miele; Merlin Nanayakkara; Riccardo Troncone; Salvatore Auricchio
Journal:  Gut       Date:  2006-08-04       Impact factor: 23.059

2.  Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer.

Authors:  V Vasko; M Saji; E Hardy; M Kruhlak; A Larin; V Savchenko; M Miyakawa; O Isozaki; H Murakami; T Tsushima; K D Burman; C De Micco; M D Ringel
Journal:  J Med Genet       Date:  2004-03       Impact factor: 6.318

3.  Enterocyte proliferation and signaling are constitutively altered in celiac disease.

Authors:  Merlin Nanayakkara; Giuliana Lania; Mariantonia Maglio; Roberta Kosova; Marco Sarno; Alessandra Gaito; Valentina Discepolo; Riccardo Troncone; Salvatore Auricchio; Renata Auricchio; Maria Vittoria Barone
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

Review 4.  Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives.

Authors:  Ricardo Costa; Benedito A Carneiro; Sunandana Chandra; Sachin G Pai; Young Kwang Chae; Jason B Kaplan; Hannah B Garrett; Mark Agulnik; Peter A Kopp; Francis J Giles
Journal:  Drug Des Devel Ther       Date:  2016-02-29       Impact factor: 4.162

Review 5.  Rho GTPases modulate malignant transformation of tumor cells.

Authors:  Jose L Orgaz; Cecilia Herraiz; Victoria Sanz-Moreno
Journal:  Small GTPases       Date:  2014-05-08

6.  Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action.

Authors:  Gabriella Castoria; Maria Lombardi; Maria Vittoria Barone; Antonio Bilancio; Marina Di Domenico; Daniela Bottero; Flavia Vitale; Antimo Migliaccio; Ferdinando Auricchio
Journal:  J Cell Biol       Date:  2003-05-12       Impact factor: 10.539

7.  siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma.

Authors:  Henri de Martimprey; Jean-Remi Bertrand; Alfredo Fusco; Massimo Santoro; Patrick Couvreur; Christine Vauthier; Claude Malvy
Journal:  Nucleic Acids Res       Date:  2007-12-13       Impact factor: 16.971

8.  The multi-targeted tyrosine kinase inhibitor vandetanib plays a bifunctional role in non-small cell lung cancer cells.

Authors:  Yan Zhou; Yuanliang Zhang; Hanbing Zou; Ning Cai; Xiaojing Chen; Longmei Xu; Xianming Kong; Peifeng Liu
Journal:  Sci Rep       Date:  2015-02-27       Impact factor: 4.379

9.  A celiac cellular phenotype, with altered LPP sub-cellular distribution, is inducible in controls by the toxic gliadin peptide P31-43.

Authors:  Merlin Nanayakkara; Roberta Kosova; Giuliana Lania; Marco Sarno; Alessandra Gaito; Martina Galatola; Luigi Greco; Marialaura Cuomo; Riccardo Troncone; Salvatore Auricchio; Renata Auricchio; Maria Vittoria Barone
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

10.  CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.

Authors:  C Ieranò; S Santagata; M Napolitano; F Guardia; A Grimaldi; E Antignani; G Botti; C Consales; A Riccio; M Nanayakkara; M V Barone; M Caraglia; S Scala
Journal:  Cell Death Dis       Date:  2014-07-03       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.